Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 14-Nov-24 4:18 PM View:  | Degolyer Donald W Director | Emergent BioSolutions, Inc. (EBS) | 12-Nov-24 | Sale | 25,000 | $10.91 | $272,750.00 | (18%) 136.1K to 111.1K | |
| 12-Jul-24 4:33 PM View: | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec | Emergent BioSolutions, Inc. (EBS) | 11-Jul-24 | Grant | 15,000 | -- | -- | 9% 171.38K to 186.38K | |
| 12-Jul-24 4:33 PM View: | Hartzel William SVP, Bioservices | Emergent BioSolutions, Inc. (EBS) | 11-Jul-24 | Grant | 15,000 | -- | -- | 45% 33.11K to 48.11K | |
| 10-Jul-24 4:02 PM View: | Williams Paul Anthony SVP, Products Business | Emergent BioSolutions, Inc. (EBS) | 08-Jul-24 | Payment of Exercise | 85 | $8.13 | $691.05 | (< 1%) 24.42K to 24.33K | |
| 11-Jun-24 4:10 PM View: | Hartzel William SVP, Bioservices | Emergent BioSolutions, Inc. (EBS) | 08-Jun-24 | Payment of Exercise | 1,167 | $6.19 | $7,223.73 | (3%) 34.27K to 33.11K | |
| 11-Jun-24 4:10 PM View: | Williams Paul Anthony SVP, Products Business | Emergent BioSolutions, Inc. (EBS) | 08-Jun-24 | Payment of Exercise | 464 | $6.19 | $2,872.16 | (2%) 24.88K to 24.42K | |
| 11-Jun-24 4:10 PM View: | Lindahl Richard S EVP, Chief Financial Officer | Emergent BioSolutions, Inc. (EBS) | 08-Jun-24 | Payment of Exercise | 2,733 | $6.19 | $16,917.30 | (2%) 158.74K to 156.01K | |
| 11-Jun-24 4:10 PM View: | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec | Emergent BioSolutions, Inc. (EBS) | 08-Jun-24 | Payment of Exercise | 2,376 | $6.19 | $14,707.40 | (1%) 173.76K to 171.38K | |
| 11-Jun-24 4:10 PM View: | Glessner Coleen EVP, Quality & Ethics, and CPL | Emergent BioSolutions, Inc. (EBS) | 08-Jun-24 | Payment of Exercise | 1,249 | $6.19 | $7,731.31 | (< 1%) 164.38K to 163.13K | |
| 06-Jun-24 4:16 PM View: | Zoon Kathryn C Director | Emergent BioSolutions, Inc. (EBS) | 04-Jun-24 | Sale | 10,000 | $6.11 | $61,100.00 | (16%) 64.48K to 54.48K | |
| 31-May-24 3:02 PM View: | Zoon Kathryn C Director | Emergent BioSolutions, Inc. (EBS) | 29-May-24 | Sale | 1,830 | $4.61 | $8,436.30 | (3%) 66.31K to 64.48K | |
| 28-May-24 9:14 PM View: | Richard Ronald Director | Emergent BioSolutions, Inc. (EBS) | 23-May-24 | Grant | 17,430 | -- | -- | 32% 53.68K to 71.11K | |
| 28-May-24 9:14 PM View: | Harsanyi Zsolt Chairman Director | Emergent BioSolutions, Inc. (EBS) | 23-May-24 | Grant | 17,430 | -- | -- | 24% 71.9K to 89.33K | |
| 28-May-24 9:14 PM View: | Zoon Kathryn C Director | Emergent BioSolutions, Inc. (EBS) | 23-May-24 | Grant | 17,430 | -- | -- | 36% 48.88K to 66.31K | |
| 28-May-24 9:14 PM View: | Sullivan Louis Director | Emergent BioSolutions, Inc. (EBS) | 23-May-24 | Grant | 17,430 | -- | -- | 20% 87.27K to 104.69K | |
| 28-May-24 9:41 PM View: | Degolyer Donald W Director | Emergent BioSolutions, Inc. (EBS) | 23-May-24 | Grant | 17,430 | -- | -- | 15% 118.67K to 136.1K | |
| 28-May-24 9:41 PM View: | Fowler Neal Franklin Director | Emergent BioSolutions, Inc. (EBS) | 23-May-24 | Grant | 17,430 | -- | -- | 15% 118.67K to 136.1K | |
| 28-May-24 9:41 PM View: | Katkin Keith Director | Emergent BioSolutions, Inc. (EBS) | 23-May-24 | Grant | 17,430 | -- | -- | 41% 42.44K to 59.87K | |
| 28-May-24 9:40 PM View: | White Marvin L Director | Emergent BioSolutions, Inc. (EBS) | 23-May-24 | Grant | 17,430 | -- | -- | 34% 50.95K to 68.38K | |
| 28-May-24 9:40 PM View: | Dayal Sujata Tyagi Director | Emergent BioSolutions, Inc. (EBS) | 23-May-24 | Grant | 17,430 | -- | -- | 38% 45.7K to 63.13K | |
| 23-May-24 5:15 PM View: | Zoon Kathryn C Director | Emergent BioSolutions, Inc. (EBS) | 21-May-24 | Sale | 1,089 | $5.78 | $6,294.42 | (2%) 49.97K to 48.88K | |
| 09-Apr-24 7:27 PM View: | Hartzel William SVP, Bioservices | Emergent BioSolutions, Inc. (EBS) | 07-Apr-24 | Payment of Exercise | 665 | $2.29 | $1,522.85 | (2%) 34.94K to 34.27K | |
| 09-Apr-24 7:27 PM View: | Glessner Coleen EVP, Quality & Ethics, and CPL | Emergent BioSolutions, Inc. (EBS) | 07-Apr-24 | Payment of Exercise | 585 | $2.29 | $1,339.65 | (< 1%) 164.97K to 164.38K | |
| 07-Mar-24 8:31 PM View: | Hartzel William SVP, Bioservices | Emergent BioSolutions, Inc. (EBS) | 05-Mar-24 | Payment of Exercise | 346 | $3.41 | $1,179.86 | (< 1%) 35.28K to 34.94K | |
| 04-Mar-24 6:42 PM View: | Lindahl Richard S EVP, Chief Financial Officer | Emergent BioSolutions, Inc. (EBS) | 01-Mar-24 | Payment of Exercise | 684 | $3.39 | $2,318.76 | (< 1%) 159.43K to 158.74K | |
| 04-Mar-24 6:43 PM View: | Glessner Coleen EVP, Quality & Ethics, and CPL | Emergent BioSolutions, Inc. (EBS) | 01-Mar-24 | Payment of Exercise | 381 | $3.39 | $1,291.59 | (< 1%) 165.35K to 164.97K | |
| 04-Mar-24 6:42 PM View: | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec | Emergent BioSolutions, Inc. (EBS) | 01-Mar-24 | Payment of Exercise | 703 | $3.39 | $2,383.17 | (< 1%) 174.46K to 173.76K | |
| 04-Mar-24 6:43 PM View: | Williams Paul Anthony SVP, Products Business | Emergent BioSolutions, Inc. (EBS) | 01-Mar-24 | Payment of Exercise | 137 | $3.39 | $464.43 | (< 1%) 25.02K to 24.88K | |
| 04-Mar-24 6:42 PM View: | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec | Emergent BioSolutions, Inc. (EBS) | 29-Feb-24 | Payment of Exercise | 4,103 | $3.23 | $13,252.70 | (2%) 178.56K to 174.46K | |
| 04-Mar-24 6:43 PM View: | Williams Paul Anthony SVP, Products Business | Emergent BioSolutions, Inc. (EBS) | 29-Feb-24 | Payment of Exercise | 450 | $3.23 | $1,453.50 | (2%) 25.47K to 25.02K | |
| 04-Mar-24 6:42 PM View: | Lindahl Richard S EVP, Chief Financial Officer | Emergent BioSolutions, Inc. (EBS) | 29-Feb-24 | Payment of Exercise | 9,037 | $3.23 | $29,189.50 | (5%) 168.46K to 159.43K | |
| 27-Feb-24 8:28 PM View: | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec | Emergent BioSolutions, Inc. (EBS) | 23-Feb-24 | Payment of Exercise | 229 | $2.74 | $627.46 | (< 1%) 178.79K to 178.56K | |
| 27-Feb-24 8:30 PM View: | Williams Paul Anthony SVP, Products Business | Emergent BioSolutions, Inc. (EBS) | 23-Feb-24 | Payment of Exercise | 105 | $2.74 | $287.70 | (< 1%) 25.57K to 25.47K | |
| 27-Feb-24 8:26 PM View: | Lindahl Richard S EVP, Chief Financial Officer | Emergent BioSolutions, Inc. (EBS) | 23-Feb-24 | Payment of Exercise | 517 | $2.74 | $1,416.58 | (< 1%) 168.98K to 168.46K | |
| 27-Feb-24 8:26 PM View: | Lindahl Richard S EVP, Chief Financial Officer | Emergent BioSolutions, Inc. (EBS) | 21-Feb-24 | Disposition | 4,012 | $2.71 | $10,872.50 | (2%) 172.99K to 168.98K | |
| 14-Nov-23 7:27 PM View: | Williams Paul Anthony SVP, Products Business | Emergent BioSolutions, Inc. (EBS) | 13-Nov-23 | Payment of Exercise | 566 | $1.82 | $1,030.12 | (2%) 26.14K to 25.57K | |
| 14-Nov-23 7:28 PM View: | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec | Emergent BioSolutions, Inc. (EBS) | 11-Nov-23 | Payment of Exercise | 413 | $2.00 | $826.00 | (< 1%) 179.21K to 178.79K | |
| 14-Nov-23 7:26 PM View: | Hartzel William SVP, Bioservices | Emergent BioSolutions, Inc. (EBS) | 11-Nov-23 | Payment of Exercise | 632 | $2.00 | $1,264.00 | (2%) 35.92K to 35.28K | |
| 05-Oct-23 7:08 PM View: | Degolyer Donald W Director | Emergent BioSolutions, Inc. (EBS) | 03-Oct-23 | Grant | 118,670 | -- | -- | 100% 0 to 118.67K | |
| 05-Oct-23 7:10 PM View: | Fowler Neal Franklin Director | Emergent BioSolutions, Inc. (EBS) | 03-Oct-23 | Grant | 118,670 | -- | -- | 100% 0 to 118.67K | |
| 24-Jul-23 8:29 AM View: | Williams Paul Anthony SVP, Products Business | Emergent BioSolutions, Inc. (EBS) | 08-Jul-23 | Payment of Exercise | 85 | -- | -- | (< 1%) 26.23K to 26.14K | |
| 13-Jun-23 10:00 PM View: | Kramer Robert President and CEO Director | Emergent BioSolutions, Inc. (EBS) | 09-Jun-23 | Grant | 212,308 | -- | -- | 72% 293.75K to 506.06K | |
| 13-Jun-23 10:00 PM View: | Williams Paul Anthony SVP, Products Business | Emergent BioSolutions, Inc. (EBS) | 09-Jun-23 | Grant | 13,847 | -- | -- | 112% 12.38K to 26.23K | |
| 24-Jul-23 8:28 AM View: | Zoon Kathryn C Director | Emergent BioSolutions, Inc. (EBS) | 02-Jun-23 | Sale (Planned) | 1,830 | $8.35 | $15,280.50 | (4%) 51.8K to 49.97K | |
| 24-Jul-23 8:28 AM View: | Zoon Kathryn C Director | Emergent BioSolutions, Inc. (EBS) | 25-May-23 | Sale (Planned) | 1,700 | $8.38 | $14,246.00 | (3%) 53.5K to 51.8K | |
| 30-May-23 7:04 PM View: | Harsanyi Zsolt Chairman Director | Emergent BioSolutions, Inc. (EBS) | 25-May-23 | Grant | 33,847 | -- | -- | 89% 38.05K to 71.9K | |
| 30-May-23 7:06 PM View: | Richard Ronald Director | Emergent BioSolutions, Inc. (EBS) | 25-May-23 | Grant | 33,847 | -- | -- | 171% 19.84K to 53.68K | |
| 30-May-23 7:07 PM View: | Sullivan Louis Director | Emergent BioSolutions, Inc. (EBS) | 25-May-23 | Grant | 33,847 | -- | -- | 63% 53.42K to 87.27K | |
| 30-May-23 7:08 PM View: | Hauer Jerome M Director | Emergent BioSolutions, Inc. (EBS) | 25-May-23 | Grant | 33,847 | -- | -- | 143% 23.66K to 57.51K | |
| 30-May-23 7:05 PM View: | Katkin Keith Director | Emergent BioSolutions, Inc. (EBS) | 25-May-23 | Grant | 33,847 | -- | -- | 394% 8.6K to 42.44K |
